Skip to content
10-K

Annual Report

ENZO BIOCHEM, INC.

0001213900-24-091798

← back to feed
Filed
Oct 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Oct 25, 2024 52.24M sh
Shares Diluted FY 2024 · Jul 31, 2024 50.9K sh
Shares Diluted FY 2024 · Jul 31, 2023 49.16K sh
Operating Cash Flow FY 2024 · Jul 31, 2024 −$26.26M
Operating Cash Flow FY 2024 · Jul 31, 2023 −$36.98M
Long Term Debt FY 2024 · Jul 31, 2024 $189K
Long Term Debt FY 2024 · Jul 31, 2023 $269K
Cash And Equivalents FY 2024 · Jul 31, 2024 $52.37M
Cash And Equivalents FY 2024 · Jul 31, 2023 $82.37M
Stockholders Equity FY 2024 · Jul 31, 2024 $56.11M
Stockholders Equity FY 2024 · Jul 31, 2023 $78.46M
Stockholders Equity FY 2024 · Jul 31, 2022 $54.46M
Current Liabilities FY 2024 · Jul 31, 2024 $24.79M
Current Liabilities FY 2024 · Jul 31, 2023 $39.99M
Total Liabilities FY 2024 · Jul 31, 2024 $29.65M
Total Liabilities FY 2024 · Jul 31, 2023 $43.42M
Current Assets FY 2024 · Jul 31, 2024 $70.03M
Current Assets FY 2024 · Jul 31, 2023 $98.46M
Total Assets FY 2024 · Jul 31, 2024 $85.76M
Total Assets FY 2024 · Jul 31, 2023 $121.88M
Eps Diluted FY 2024 · Jul 31, 2024 −$0.51
Eps Diluted FY 2024 · Jul 31, 2023 $0.41
Eps Basic FY 2024 · Jul 31, 2024 −$0.51
Eps Basic FY 2024 · Jul 31, 2023 $0.41
Sga Expense FY 2024 · Jul 31, 2024 $21.72M
Sga Expense FY 2024 · Jul 31, 2023 $27.2M
Rd Expense FY 2024 · Jul 31, 2024 $2.64M
Rd Expense FY 2024 · Jul 31, 2023 $3.9M
Net Income FY 2024 · Jul 31, 2024 −$26.08M
Net Income FY 2024 · Jul 31, 2023 $20.29M
Operating Income FY 2024 · Jul 31, 2024 −$12.37M
Operating Income FY 2024 · Jul 31, 2023 −$24.74M
Cost Of Revenue FY 2024 · Jul 31, 2024 $17.28M
Cost Of Revenue FY 2024 · Jul 31, 2023 $17.87M
Revenue FY 2024 · Jul 31, 2024 $31.91M
Revenue FY 2024 · Jul 31, 2023 $31.06M